Extensively Drug-Resistant Tuberculosis
"Extensively Drug-Resistant Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.
| Descriptor ID |
D054908
|
| MeSH Number(s) |
C01.252.410.040.552.846.775.500
|
| Concept/Terms |
Extensively Drug-Resistant Tuberculosis- Extensively Drug-Resistant Tuberculosis
- Extensively Drug Resistant Tuberculosis
- Extremely Drug-Resistant Tuberculosis
- Drug-Resistant Tuberculoses, Extremely
- Drug-Resistant Tuberculosis, Extremely
- Extremely Drug Resistant Tuberculosis
- Extremely Drug-Resistant Tuberculoses
- Tuberculoses, Extremely Drug-Resistant
- Tuberculosis, Extremely Drug-Resistant
- Tuberculosis, Extremely Drug Resistant
- XDR-TB
- Tuberculosis, Extensively Drug-Resistant
- Drug-Resistant Tuberculoses, Extensively
- Drug-Resistant Tuberculosis, Extensively
- Extensively Drug-Resistant Tuberculoses
- Tuberculoses, Extensively Drug-Resistant
- Tuberculosis, Extensively Drug Resistant
|
Below are MeSH descriptors whose meaning is more general than "Extensively Drug-Resistant Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Extensively Drug-Resistant Tuberculosis".
This graph shows the total number of publications written about "Extensively Drug-Resistant Tuberculosis" by people in this website by year, and whether "Extensively Drug-Resistant Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 3 | 2 | 5 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 4 | 0 | 4 |
| 2018 | 4 | 0 | 4 |
| 2019 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Extensively Drug-Resistant Tuberculosis" by people in Profiles.
-
The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif. J Infect. 2025 Feb; 90(2):106399.
-
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland. Respiration. 2024; 103(9):593-600.
-
Multidrug-resistant tuberculosis. Nat Rev Dis Primers. 2024 Mar 24; 10(1):22.
-
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis. J Infect. 2023 09; 87(3):177-189.
-
Availability and costs of medicines for the treatment of tuberculosis in Europe. Clin Microbiol Infect. 2023 Jan; 29(1):77-84.
-
Evidence-based Definition for Extensively Drug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2021 09 15; 204(6):713-722.
-
A systemic approach to explore the mechanisms of drug resistance and altered signaling cascades in extensively drug-resistant tuberculosis. Adv Protein Chem Struct Biol. 2021; 127:343-364.
-
New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared? Am J Respir Crit Care Med. 2019 08 15; 200(4):514-515.
-
Revising the definition of extensively drug-resistant tuberculosis. Lancet Respir Med. 2018 12; 6(12):893-895.
-
Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 04; 6(4):240-242.